| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(17)30340-7 |
| P698 | PubMed publication ID | 28653626 |
| P50 | author | Mauro M Teixeira | Q43261431 |
| Suresh Mahalingam | Q55190793 | ||
| P2093 | author name string | Scott B Halstead | |
| P2860 | cites work | Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 |
| Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Q24737245 | ||
| Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | Q25161212 | ||
| Zika-induced antibody response enhances dengue serotype 2 replication in vitro | Q26262372 | ||
| Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored | Q27489549 | ||
| Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand | Q31032937 | ||
| Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes | Q34671059 | ||
| Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil | Q37358125 | ||
| A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand | Q37443026 | ||
| Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection | Q38087545 | ||
| Effect of age on outcome of secondary dengue 2 infections | Q39038283 | ||
| Zika virus infection, associated microcephaly, and low yellow fever vaccination coverage in Brazil: is there any causal link? | Q40057291 | ||
| P433 | issue | 7 | |
| P921 | main subject | Zika virus | Q202864 |
| P1104 | number of pages | 3 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 686-688 | |
| P577 | publication date | 2017-06-21 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Zika enhancement: a reality check | |
| P478 | volume | 17 |
| Q99634545 | ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis |
| Q61053638 | Does prior dengue virus exposure worsen clinical outcomes of Zika virus infection? A systematic review, pooled analysis and lessons learned |
| Q41995967 | Enhancement of Zika Infection by Dengue-Specific Antibodies Does Not Alter the Production of Interleukin 6 in FcγRII-Expressing K562 Cells |
| Q66680070 | In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q58742686 | Zika Virus Vaccines: Challenges and Perspectives |
Search more.